PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

McMaster University researchers find fever-reducing medications may aid spread of influenza

2014-01-22
(Press-News.org) Contact information: Veronica McGuire
vmcguir@mcmaster.ca
905-525-9140 ext. 22169
McMaster University
McMaster University researchers find fever-reducing medications may aid spread of influenza Hamilton, ON (Jan. 21, 2014) -- Contrary to popular belief, fever-reducing medication may inadvertently cause more harm than good.

New research from McMaster University has discovered that the widespread use of medications that contain fever-reducing drugs may lead to tens of thousands more influenza cases, and more than a thousand deaths attributable to influenza, each year across North America. These drugs include ibuprofen, acetaminophen and acetylsalicylic acid.

"When they have flu, people often take medication that reduces their fever. No-one likes to feel miserable, but it turns out that our comfort might be at the cost of infecting others," said lead author David Earn, an investigator with the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) and professor of mathematics at McMaster University.

"Because fever can actually help lower the amount of virus in a sick person's body and reduce the chance of transmitting disease to others, taking drugs that reduce fever can increase transmission. We've discovered that this increase has significant effects when we scale up to the level of the whole population."

The study, published in the Proceedings of the Royal Society B today, was co-authored with McMaster professors Ben Bolker, of the departments of mathematics & statistics and biology and the IIDR, and Paul Andrews of the Department of Psychology, Neuroscience and Behaviour.

"People often take -- or give their kids -- fever-reducing drugs so they can go to work or school," Earn said. "They may think the risk of infecting others is lower because the fever is lower. In fact, the opposite may be true: the ill people may give off more virus because fever has been reduced."

The researchers assembled information from many sources, including experiments on human volunteers and on ferrets (which are the best animal model for human influenza). They then used a mathematical model to compute how the increase in the amount of virus given off by a single person taking fever-reducing drugs would increase the overall number of cases in a typical year, or in a year when a new strain of influenza caused a flu pandemic.

The bottom line is that fever suppression increases the number of annual cases by approximately five per cent, corresponding to more than 1,000 additional deaths from influenza in a typical year across North America.

"This research is important because it will help us understand how better to curb the spread of influenza," said David Price, professor and chair of family medicine for McMaster's Michael G. DeGroote School of Medicine.

The family physician agrees with the researchers' conclusions. "As always, Mother Nature knows best. Fever is a defence mechanism to protect ourselves and others. Fever-reducing medication should only be taken to take the edge off the discomfort, not to allow people to go out into the community when they should still stay home."

"People are often advised to take fever-reducing drugs and medical texts state that doing so is harmless," added Andrews. "This view needs to change."

The research findings echo previous research that has shown how the widespread use of medication can have unwanted effects on the transmission of disease. For example, it is now well accepted that the indiscriminate use of antibiotics has driven the emergence of life-threatening antibiotic resistant bacteria.

Bolker said: "Parents and health care professionals alike have focused on making their children or patients feel better by reducing fever, without being aware of potentially harmful side effects at the population level.

"Although we have put together the best available estimates for each parameter in our model, we have a long way to go before we can make concrete policy proposals.

"We need more experiments to determine precisely how much reducing fever increases viral shedding in humans, and to estimate how much more people spread disease because they are more active in the community when they alleviate their symptoms by taking medication."

### The study was supported by the Natural Sciences and Engineering Research Council of Canada and the Michael G. DeGroote Institute for Infectious Disease Research.

Note to Editors

A photo of the McMaster researchers can be found at: http://fhs.mcmaster.ca/media/fever/

For further information

Veronica McGuire
Media Relations
Faculty of Health Science
McMaster University
905-525-9140, ext. 22169
vmcguir@mcmaster.ca


ELSE PRESS RELEASES FROM THIS DATE:

Calcium absorption not the cause of evolution of milk digestion in Europeans

2014-01-22
Calcium absorption not the cause of evolution of milk digestion in Europeans Ancient DNA from early Iberian farmers shows that the wideheld evolutionary hypothesis of calcium absorption was not the only reason Europeans evolved milk tolerance. Most ...

How the genetic blueprints for limbs came from fish

2014-01-22
How the genetic blueprints for limbs came from fish A study led by Denis Duboule shows that these appendages have emerged during evolution by modernisation of a preexisting DNA structure The transition from water to land is one of the most fascinating enigmas ...

Exercising more, sitting less reduces heart failure risk in men

2014-01-22
Exercising more, sitting less reduces heart failure risk in men American Heart Association Rapid Access Journal Report Sitting for long periods increases heart failure risk in men, even for those who exercise regularly, according to new research published in ...

Wide variation found in quality of evidence used by FDA for approval of new drugs

2014-01-22
Wide variation found in quality of evidence used by FDA for approval of new drugs Clinical trials used by the Food and Drug Administration (FDA) to approve new drugs between 2005 and 2012 vary widely in their characteristics, according to a study in the January ...

Study examines reasons for delay, denial of new drugs by FDA

2014-01-22
Study examines reasons for delay, denial of new drugs by FDA Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs ...

Biomarkers in blood show potential as early detection method of pancreatic cancer

2014-01-22
Biomarkers in blood show potential as early detection method of pancreatic cancer Researchers have identified diagnostic microRNA panels in whole blood that had the ability to distinguish, to some degree, patients with and without pancreatic cancer, according ...

Many CV devices approved by process that often does not require new clinical data

2014-01-22
Many CV devices approved by process that often does not require new clinical data Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective ...

Mediterranean diet associated with lower risk of peripheral artery disease

2014-01-22
Mediterranean diet associated with lower risk of peripheral artery disease A multicenter study that previously reported a reduction in heart attack and stroke with a Mediterranean diet supplemented with extra-virgin olive oil or with nuts now also reports a ...

Deaths higher for heart attack patients at night and weekends

2014-01-22
Deaths higher for heart attack patients at night and weekends Research: Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis Mortality is higher, and emergency treatment takes longer, for ...

Long term exposure to air pollution linked to coronary events

2014-01-22
Long term exposure to air pollution linked to coronary events Association persists at levels of exposure below current European limits Long term exposure to particulate matter in outdoor air is strongly linked to heart attacks and angina, and this association ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] McMaster University researchers find fever-reducing medications may aid spread of influenza